Cargando…

Meningococcal disease in adolescents and young adults: a review of the rationale for prevention through vaccination

Invasive meningococcal disease (IMD) caused by Neisseria meningitidis is characterized by high mortality and morbidity. While IMD incidence peaks in both infants and adolescents/young adults, carriage rates are often highest in the latter age groups, increasing IMD risk and the likelihood of transmi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Burman, Cynthia, Serra, Lidia, Nuttens, Charles, Presa, Jessica, Balmer, Paul, York, Laura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6422514/ https://www.ncbi.nlm.nih.gov/pubmed/30273506 http://dx.doi.org/10.1080/21645515.2018.1528831

Ejemplares similares

Impact of meningococcal vaccination on carriage and disease transmission: A review of the literature
por: Balmer, Paul, et al.
Publicado: (2018)

Preventing invasive meningococcal disease in early infancy
por: Presa, Jessica, et al.
Publicado: (2022)

Serum bactericidal activity against circulating and reference strains of meningococcal serogroup B in the United States: A review of the strain coverage of meningococcal serogroup B (MenB) vaccines in adolescents and young adults
por: Presa, Jessica, et al.
Publicado: (2023)

A Review of Meningococcal Disease and Vaccination Recommendations for Travelers
por: Serra, Lidia C., et al.
Publicado: (2018)

Vaccination strategies for the prevention of meningococcal disease
por: Vuocolo, Scott, et al.
Publicado: (2018)

01. Serum Bactericidal Activity Against Circulating and Reference Strains of Meningococcal Serogroup B in the United States: A Review of Meningococcal Serogroup B (MenB) Vaccines in Adolescents and Young Adults
por: Coyne-Beasley, Tamera, et al.
Publicado: (2021)

Rationale for the Development of a Pentavalent Meningococcal Vaccine: A US-Focused Review
por: Marshall, Gary S., et al.
Publicado: (2022)

2455. Is Category B Working? Uptake Patterns of Meningococcal Group B Vaccine Among US Adolescents and Young Adults
por: Khan, Farid L, et al.
Publicado: (2018)

Incidence and Prevention of Invasive Meningococcal Disease in Global Mass Gathering Events
por: Muttalif, Abdul Razak, et al.
Publicado: (2019)

Epidemiologic Trends, Global Shifts in Meningococcal Vaccination Guidelines, and Data Supporting the Use of MenACWY-TT Vaccine: A Review
por: Presa, Jessica, et al.
Publicado: (2019)

3. A Review of the Clinical Development of MenACWY-TT, a Quadrivalent Meningococcal Vaccine Conjugated to Tetanus Toxoid, in Adolescents
por: Peyrani, Paula, et al.
Publicado: (2020)

Atypical presentation of invasive meningococcal disease caused by serogroup W meningococci
por: Stinson, C., et al.
Publicado: (2020)

Concomitant administration of meningococcal vaccines with other vaccines in adolescents and adults: a review of available evidence
por: Alderfer, Justine, et al.
Publicado: (2019)

The Impact of Social Determinants of Health on Meningococcal Vaccination Awareness, Delivery, and Coverage in Adolescents and Young Adults in the United States: A Systematic Review
por: Masaquel, Catherine, et al.
Publicado: (2023)

Evolution of invasive meningococcal disease epidemiology in Europe, 2008 to 2017
por: Nuttens, Charles, et al.
Publicado: (2022)

Infant Meningococcal Vaccination: Advisory Committee on Immunization Practices (ACIP) Recommendations and Rationale
por: Rubin, Lorry, et al.
Publicado: (2013)

2. Understanding Patient Preferences for Meningococcal Serogroup B Vaccines in the United States
por: Johnson, Reed, et al.
Publicado: (2020)

27. Immunologic Hyporesponsiveness with Subsequent Dosing of Meningococcal Vaccines: Re-Evaluating the Current Paradigm
por: Findlow, Jamie, et al.
Publicado: (2021)

Systematic literature review of the impact and effectiveness of monovalent meningococcal C conjugated vaccines when used in routine immunization programs
por: Tin Tin Htar, Myint, et al.
Publicado: (2020)

Using the tetravalent meningococcal polysaccharide-protein conjugate vaccine in the prevention of meningococcal disease
por: Kimmel, Sanford R
Publicado: (2008)

Randomized Trial of 2 Schedules of Meningococcal B Vaccine in Adolescents and Young Adults, Canada
por: Langley, Joanne M., et al.
Publicado: (2020)

Control of meningococcal meningitis with meningococcal vaccines.
por: Artenstein, M. S.
Publicado: (1975)

MenB-FHbp Vaccine Protects Against Diverse Meningococcal Strains in Adolescents and Young Adults: Post Hoc Analysis of Two Phase 3 Studies
por: Beeslaar, Johannes, et al.
Publicado: (2020)

Meningococcal Vaccinations
por: Crum-Cianflone, Nancy, et al.
Publicado: (2016)

Meningococcal Carriage among Adolescents after Mass Meningococcal C Conjugate Vaccination Campaigns in Salvador, Brazil
por: Nunes, Amélia Maria Pithon Borges, et al.
Publicado: (2016)

1083 Comparative Evaluation of Two Different Investigational Meningococcal ABCWY Vaccine Formulations in Adolescents and Young Adults
por: Block, Stan L., et al.
Publicado: (2014)

A review of complement sources used in serum bactericidal assays for evaluating immune responses to meningococcal ACWY conjugate vaccines
por: Findlow, Jamie, et al.
Publicado: (2019)

Economic evaluation of meningococcal vaccines: considerations for the future
por: Christensen, Hannah, et al.
Publicado: (2019)

Meningococcal Group B Vaccine For The Prevention Of Invasive Meningococcal Disease Caused By Neisseria meningitidis Serogroup B
por: Rivero-Calle, Irene, et al.
Publicado: (2019)

Meningococcal Vaccination:: An Update on Meningococcal Vaccine Recommendations for the Primary Care Physician
por: Nichols, Justin, et al.
Publicado: (2022)

Herd Protection against Meningococcal Disease through Vaccination
por: Clark, Stephen A., et al.
Publicado: (2020)

Vaccine Preventability of Meningococcal Clone, Greater Aachen Region, Germany
por: Elias, Johannes, et al.
Publicado: (2010)

Meningococcal Group W Disease in Infants and Potential Prevention by Vaccination
por: Parikh, Sydel R., et al.
Publicado: (2016)

ROLE OF MENINGOCOCCAL ENDOTOXIN IN MENINGOCOCCAL PURPURA
por: Davis, Charles E., et al.
Publicado: (1974)

1146. Cost-effectiveness of the Pentavalent Meningococcal Vaccine (MenABCWY): A steady-state cohort modelling approach
por: Schley, Katharina, et al.
Publicado: (2023)

Sex-Related Differences in the Immune Response to Meningococcal Vaccinations During Adolescence
por: Ohm, Milou, et al.
Publicado: (2022)

Experience implementing a university-based mass immunization program in response to a meningococcal B outbreak
por: Capitano, Blair, et al.
Publicado: (2019)

6. Pentavalent Meningococcal (MenABCWY) Vaccine is Safe and Well Tolerated With Immunogenicity Noninferior to Coadministered MenB-FHbp and MenACWY-CRM in a Phase 2 Study of Healthy Adolescents and Young Adults
por: Peterson, James, et al.
Publicado: (2020)

Impact of vaccination on meningococcal epidemiology
por: Stefanelli, Paola, et al.
Publicado: (2015)

Vaccines against Meningococcal Diseases
por: Pizza, Mariagrazia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0t0ihr1j4kf29svvce6no00rgj